Dr. Jessica Moe and her team were awarded $1.3 million in funding over five years from the Health Canada Substance Use and Addictions Program. This grant will support their study that aims to optimize emergency department screening for opioid use disorder, and evaluate standard dosing and microdosing approaches to buprenorphine/naloxone inductions initiated in the ED setting.